SPONSOR
Guangdong Provincial People's Hospital
Total Trials
7
Recruiting
7
Phases
Phase 2, Phase 4
Conditions studied: Emergency MedicineIgA NephropathySCLC, Limited StageSoft Tissue SarcomaDoxorubicinRadiotherapyAI (Artificial Intelligence)Renal Anemia of Chronic Kidney DiseaseAcute Myeloid Leukemia
Guangdong Provincial People's Hospital is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Emergency Medicine, IgA Nephropathy, SCLC, Limited Stage, Soft Tissue Sarcoma.
The trial portfolio spans Phase 2, Phase 4 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Guangdong Provincial People's Hospital
How many clinical trials has Guangdong Provincial People's Hospital sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Guangdong Provincial People's Hospital, of which 7 are actively recruiting participants. These trials cover conditions including Emergency Medicine, IgA Nephropathy, SCLC, Limited Stage. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Guangdong Provincial People's Hospital research focus on?
Guangdong Provincial People's Hospital clinical trials span Emergency Medicine, IgA Nephropathy, SCLC, Limited Stage, Soft Tissue Sarcoma, Doxorubicin, and additional conditions. The research pipeline includes Phase 2, Phase 4 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Guangdong Provincial People's Hospital clinical trial?
To participate in a Guangdong Provincial People's Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Guangdong Provincial People's Hospital trials with current recruitment status updated daily.
Clinical Trials by Guangdong Provincial People's Hospital
NCT05616416
Recruiting
International Big Data Centre in Emergency Medicine
Emergency Medicine
NCT05190848
Recruiting
Correlation of Microbiome and Metabonomics With IgA Nephropathy
IgA Nephropathy
NCT06911606 Phase 2
Recruiting
Study of Serplulimab Plus Chemotherapy as Neoadjuvant Therapy for Limited-stage Small Cell Lung Cancer (LS-SCLC)
SCLC, Limited Stage
NCT06506838 Phase 4
Recruiting
Anlotinib Combined With Doxorubicin and Radiotherapy as Neoadjuvant Treatment for Soft Tissue Sarcoma
Soft Tissue Sarcoma
NCT07505862
Recruiting
Scientific Validity Assessment and Optimization of AI-Generated A3/A4 Type Questions for the Chinese Medical Licensing Examination
AI (Artificial Intelligence)
NCT07136792
Recruiting
A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI)
Renal Anemia of Chronic Kidney Disease
NCT06451861 Phase 2
Recruiting
Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML
Acute Myeloid Leukemia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology